Jiayin Liu

ORCID: 0000-0001-9237-0823
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Neonatal Respiratory Health Research
  • Cancer, Hypoxia, and Metabolism
  • RNA modifications and cancer
  • Cancer-related gene regulation
  • Lung Cancer Treatments and Mutations
  • Congenital Diaphragmatic Hernia Studies
  • Ultrasound and Hyperthermia Applications
  • Connective tissue disorders research
  • Photodynamic Therapy Research Studies
  • Antimicrobial Peptides and Activities
  • Colorectal and Anal Carcinomas
  • Sexual Differentiation and Disorders
  • Infant Development and Preterm Care
  • Gut microbiota and health
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Cancer Immunotherapy and Biomarkers
  • Pelvic and Acetabular Injuries
  • Parathyroid Disorders and Treatments
  • Reproductive System and Pregnancy
  • Hip and Femur Fractures
  • Medical Imaging and Pathology Studies
  • Metabolism, Diabetes, and Cancer
  • Colorectal Cancer Screening and Detection
  • Amino Acid Enzymes and Metabolism
  • RNA Research and Splicing

Hebei Medical University
2022-2025

Fourth Hospital of Hebei Medical University
2022-2025

Sun Yat-sen University
2025

Fujian Agriculture and Forestry University
2025

Nanjing Medical University
2009-2024

Jiangsu Province Hospital
2017-2024

Suzhou Municipal Hospital
2022

First Affiliated Hospital of Zhengzhou University
2021

North China University of Science and Technology
2017

China Pharmaceutical University
2009

Colorectal cancer (CRC) presents a complex tumor microenvironment influenced by genetic and microbial factors. Microbial DNA from the gut can translocate into bloodstream, forming circulating microbiome associated with prognosis clinicopathological features. This study investigates peripheral venous blood in CRC patients using 2bRAD-M sequencing evaluates its clinical significance. Peripheral samples 29 (19 males, 10 females; mean age 57 years) healthy controls were analyzed to assess...

10.1186/s12967-025-06164-4 article EN cc-by-nc-nd Journal of Translational Medicine 2025-02-13

This study explores the benefits of targeted-immunotherapy combination in third-line or beyond treatment for microsatellite stable (MSS) metastatic colorectal cancer (mCRC) a real-world setting.

10.3389/fimmu.2024.1462346 article EN cc-by Frontiers in Immunology 2024-10-24

Abstract Background Enolase 1 (ENO1) is a metabolic enzyme which participates in pyruvate synthesis and ATP production cells. Previously, differential expression of ENO1 was discovered villous tissues between recurrent miscarriage induced abortion. This study designed to explore whether influences the proliferation invasion trophoblasts related molecular mechanisms. Methods First, placental villus collected from (RM) patients women for abortion as well trophoblast‐derived cell lines detected...

10.1002/mgg3.2220 article EN cc-by-nc-nd Molecular Genetics & Genomic Medicine 2023-06-08

Acute lung injury (ALI) is one of the most common clinical emergencies with limited effective pharmaceutical treatment in clinic, especially when it progresses to acute respiratory distress syndrome (ARDS). Currently, mesenchymal stem cells (MSCs) exhibit specific superiority for ALI/ARDS treatment. However, from different sources may result controversial effects on similar disease conditions. This study aimed determine human amnion-derived (hAMSCs) two ALI mice model. The administered...

10.3389/fphar.2023.1149659 article EN cc-by Frontiers in Pharmacology 2023-06-14

Lorlatinib has been suggested as the therapeutic option for patients with ROS1-rearranged non-small-cell lung cancer (NSCLC) after ROS1 tyrosine kinase inhibitor (TKI) failure. However, mechanism mediating lorlatinib resistance not well elucidated in NSCLC. Post- options remain scarce.Herein, we describe a 31-year-old female patient stage IVB She received 2nd line treatment crizotinib chemotherapy failure and achieved partial response lasting 15 months. An NF1 p.G127Ter mutation emerged...

10.2147/cmar.s387211 article EN cc-by-nc Cancer Management and Research 2022-11-01

Despite evidence suggesting a significant role of pyruvate kinase muscle isozyme (PKM) in cancer development, its particular function colorectal (CRC) remains unclear. This study aimed to elucidate the specific and mechanism PKM isoforms, PKM1 PKM2, progression CRC.

10.21037/tcr-24-154 article EN Translational Cancer Research 2024-07-01

Abstract Background Calciphylaxis, which mostly affects individuals with end-stage kidney disease (ESKD), is also known as calcific uremic arteriolopathy (CUA). It a rare and fatal that manifests calcification thrombosis of microvessels, ischemia, necrosis in skin tissues(ORPHA:280062). Histopathological features extracutaneous tissues CUA patients undergoing human amnion–derived mesenchymal stem cell (hAMSC) treatment remain unknown. Methods A female patient, treated hAMSCs for 20 months,...

10.1101/2024.10.21.24315424 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2024-10-23

This study explored the correlation between peripheral blood lipid levels and clinicopathological parameters in patients with advanced gastric cancer (GC), focusing on changes during disease progression. Pathological features serum profiles of 179 stage III-IV adenocarcinoma were analyzed. Lipid examined included total cholesterol (TC), triglycerides (TG), high-density lipoprotein (HDL-C), low-density (LDL-C), very (VLDL-C), apolipoprotein AI (Apo AI), B B), lipoprotein(a) (Lp(a)), among...

10.1186/s12876-024-03479-2 article EN cc-by-nc-nd BMC Gastroenterology 2024-11-04
Coming Soon ...